A Rossi, FL Dini, P Faggiano, M Cicoira, S Frattini… - Heart, 2011 - heart.bmj.com Methods and results Patients with HF due to ischaemic and non-ischaemic dilated cardiomyopathy (DCM) were retrospectively recruited. The clinical end point was a composite of all-cause mortality and hospitalisation for worsening HF. FMR was quantitatively determined by measuring ...
[PDF] from columbiaresidents.orgT Feldman, E Foster, DG Glower, S Kar… - … England Journal of …, 2011 - Mass Medical Soc At 12 months, the rates of the primary end point for efficacy were 55% in the percutaneous-repair group and 73% in the surgery group (P=0.007). The respective rates of the components of the primary end point were as follows: death, 6% in each group; surgery for mitral-valve ... Cited by 24 - Related articles - All 7 versions
T Feldman… - Journal of the American College …, 2011 - Am Coll Cardio Found Percutaneous therapy for the treatment of mitral regurgitation has emerged rapidly over the past few years. Most of the percutaneous approaches are modifications of existing surgical approaches to mitral annuloplasty or leaflet repair. Catheter-based devices mimic these surgical ... Related articles - All 4 versions
S Chandra, IS Salgo, L Sugeng… - American Journal of …, 2011 - Am Physiological Soc ... 8 Brief title: Flow convergence in mitralregurgitation 9 10 ... 2 ABSTRACT 18 Mitral effective regurgitant orifice area (EROA) using the flow convergence (FC) method is used 19 to quantify the severity of mitralregurgitation (MR). However, it is challenging and prone to inter- 20 ... All 3 versions
H Asakai, Y Kaneko, M Kaneko, Y Misaki… - Pediatric …, 2011 - Springer Abstract This report describes six previously healthy infants with acute mitral valve chordal rupture. Although their initial symptoms were mild respiratory distress and fever, all the infants presented with acute progressive left heart failure and required urgent surgical repair. ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
